Statements (52)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:affects |
central nervous system
|
gptkbp:broadcastOn |
controlled substances (varies by drug)
|
gptkbp:can_be_abused |
yes
|
gptkbp:cause |
addiction
confusion drowsiness hypotension respiratory depression bradycardia slurred speech impaired coordination coma (in overdose) death (in overdose) memory impairment |
gptkbp:contraindicated_with |
other CNS depressants
|
gptkbp:example |
gptkb:lorazepam
gptkb:diazepam gptkb:zolpidem phenobarbital alprazolam |
https://www.w3.org/2000/01/rdf-schema#label |
CNS depressants
|
gptkbp:includes |
gptkb:beer
gptkb:benzodiazepines opioids barbiturates non-benzodiazepine sleep medications |
gptkbp:interactsWith |
gptkb:beer
opioids antipsychotics antihistamines antidepressants |
gptkbp:mechanismOfAction |
enhance GABA activity
|
gptkbp:prescribed_by |
gptkb:physician
|
gptkbp:regulates |
gptkb:FDA
|
gptkbp:riskFactor |
tolerance
overdose dependence |
gptkbp:should_not_be_mixed_with |
gptkb:beer
opioids other sedatives |
gptkbp:usedFor |
anxiety
muscle relaxation insomnia seizure disorders |
gptkbp:withdrawal_symptoms |
anxiety
delirium seizures agitation tremors |
gptkbp:bfsParent |
gptkb:Lyrica
|
gptkbp:bfsLayer |
5
|